Fanny Piette

5.0k citations

24 papers · 3.4k indexed · 3 hit papers · h-index 14

Cancer Research top 1%
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 3
Oncology top 1%
- HER2/EGFR in Cancer Research 7
- Cancer Immunotherapy and Biomarkers 2
- Cancer Treatment and Pharmacology 2
Immunology top 5%
Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 5%
- Advanced Breast Cancer Therapies 3
Physiology
- Histiocytic Disorders and Treatments 2
Pathology and Forensic Medicine
- Autoimmune Bullous Skin Diseases 2

Co-authors: Christos Sotiriou Martine Piccart Sherene Loi Giuseppe Viale Marc Buyse Fátima Cardoso Angelo Di Leo Adrian L. Harris
Cited by: Cancer Research Oncology Immunology
Journals: Journal of Clinical Oncology (4 papers)The Journal of Immunology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
Partner nations: Belgium United States France

In The Last Decade

Fanny Piette

23 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Journal of Clinical Oncology
2007 Clinical Cancer Research
2006 JNCI Journal of the National Cancer Institute

Peers

Countries citing papers authored by Fanny Piette

Since Specialization

Citations

This map shows the geographic impact of Fanny Piette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Piette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Piette more than expected).

Fields of papers citing papers by Fanny Piette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Piette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Piette. The network helps show where Fanny Piette may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fanny Piette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fanny Piette Line = papers co-authored together Fanny Piette links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10 Journal of Clinical Oncology ·Jame Abraham,A.J. Montero,Rachel C. Jankowitz,Mohamad A. Salkeni,Jan H. Beumer,Brian F. Kiesel,Fanny Piette,Laura M. Adamson,Rebecca J. Nagy,Richard B. Lanman,Jeff Sperinde,Weidong Huang,Carmen J. Allegra,Ashok Srinivasan,Ying Wang,Katherine L. Pogue–Geile,Peter C. Lucas,Samuel A. Jacobs	2019	59
2	Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types BMJ Open ·Caroline Lonez,Bikash Verma,Alain Hendlisz,Philippe Aftimos,Ahmad Awada,Eric Van Den Neste,Gaëtan Catala,Jean‐Pascal Machiels,Fanny Piette,Jason Brayer,David A. Sallman,Tessa Kerre,Kunle Odunsi,Marco L. Davila,David E. Gilham,Frédéric Lehmann	2017	42
3	Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98breakdown → Journal of Clinical Oncology ·Sherene Loi,Nicolas Sirtaine,Fanny Piette,Roberto Salgado,Giuseppe Viale,Françoise Van Eenoo,Ghizlane Rouas,Prudence A. Francis,John Crown,Erika Hitre,Evandro de Azambuja,Emmanuel Quinaux,Angelo Di Leo,Stefan Michiels,Martine Piccart,Christos Sotiriou	2013	1213
4	Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy The Oncologist ·Renata Duchnowska,Wojciech Biernat,Barbara Szostakiewicz,Jeff Sperinde,Fanny Piette,Mojgan Haddad,Agnès Paquet,Yolanda Lie,Bogumiła Czartoryska-Arłukowicz,Piotr J. Wysocki,Tomasz Jankowski,Barbara Radecka,Małgorzata Foszczyńska‐Kłoda,Maria Litwiniuk,Sylwia Dębska-Szmich,Jodi Weidler,Weidong Huang,Marc Buyse,Michael Bates,Jacek Jassem	2012	27
5	Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group Clinical Breast Cancer ·Priya Rastogi,Marc Buyse,Sandra M. Swain,Samuel A. Jacobs,André Robidoux,Marcia K. Liepman,Eduardo R. Pajon,Philip A. Dy,Juan G. Posada,Marianne K. Melnik,Fanny Piette,Charles E. Geyer,E.P. Mamounas,Norman Wolmark	2011	13
6	Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N+) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT). Journal of Clinical Oncology ·Sherene Loi,Rodrigo Salgado,Fanny Piette,Nicolas Sirtaine,Françoise Van Eenoo,Roswitha Kammler,G. Rouas,Prudence A. Francis,John Crown,Bo Nordenskjöld,Javier Gutierrez,Magnus Andersson,Mireia Margelí Vila,R. Jakesz,G. Viale,Emmanuel Quinaux,Angelo Di Leo,Stefan Michiels,C. Sotiriou,Martine Piccart	2011	5
7	Quantitation of HER2 Expression or HER2:HER2 Dimers and Differential Survival in a Cohort of Metastatic Breast Cancer Patients Carefully Selected for Trastuzumab Treatment Primarily by FISH Diagnostic Molecular Pathology ·Christine Desmedt,Jeff Sperinde,Fanny Piette,Weidong Huang,Xueguang Jin,Yuping Tan,Virginie Durbecq,Denis Larsimont,Rosa Giuliani,Colombe Chappey,Marc Buyse,John Winslow,Martine Piccart,Christos Sotiriou,Christos J. Petropoulos,Michael Bates	2009	31
8	A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy. Cancer Research ·Angelo Di Leo,J Isola,Fanny Piette,Bent Ejlertsen,Kathleen I. Pritchard,JM Bartlett,Christine Desmedt,Denis Larsimont,Minna Tanner,Henning T. Mouridsen,FP O'Malley,C.J. Twelves,Fátima Cardoso,C. J. Poole,M. Piccart,ME Buyse	2009	42
9	Comparison of prognostic gene expression signatures for breast cancer BMC Genomics ·Benjamin Haibe‐Kains,Christine Desmedt,Fanny Piette,Marc Buyse,Fátima Cardoso,Laura van’t Veer,Martine Piccart,Gianluca Bontempi,Christos Sotiriou	2008	100
10	Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Seriesbreakdown → Clinical Cancer Research ·Christine Desmedt,Fanny Piette,Sherene Loi,Yixin Wang,Françoise Lallemand,Benjamin Haibe‐Kains,Giuseppe Viale,Mauro Delorenzi,Yi Zhang,Mahasti Saghatchian d'Assignies,Jonas Bergh,Rosette Lidereau,Peter Ellis,Adrian L. Harris,Jan G.M. Klijn,John A. Foekens,Fátima Cardoso,Martine Piccart,Marc Buyse,Christos Sotiriou	2007	726
11	Paraneoplastic pemphigus with pemphigus vegetans-like lesions revealing non-Hodgkin lymphoma. PubMed ·A. Duparc,S. Boivin,D. Gilbert,Fanny Piette,E. Delaporte	2007	7
12	Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation The Journal of Immunology ·Jacques Chapiro,Stéphane Claverol,Fanny Piette,Wenbin Ma,Vincent Stroobant,Benoît Guillaume,Jean-Edouard Gairin,Sandra Morel,Odile Burlet‐Schiltz,Bernard Monsarrat,Thierry Boon,Benoı̂t J. Van den Eynde	2006	125
13	Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancerbreakdown → JNCI Journal of the National Cancer Institute ·Marc Buyse,Sherene Loi,Laura van’t Veer,Giuseppe Viale,Mauro Delorenzi,Annuska M. Glas,Mahasti Saghatchian d'Assignies,Jonas Bergh,Rosette Lidereau,Peter Ellis,Adrian L. Harris,Jan Bogaerts,Patrick Therasse,Arno Floore,Mohamed Amakrane,Fanny Piette,Emiel J. Rutgers,Christos Sotiriou,Fátima Cardoso,Martine Piccart	2006	842
14	Unrelated Donor Status and High Donor Age Independently Affect Immunologic Recovery after Nonmyeloablative Conditioning Biology of Blood and Marrow Transplantation ·Frédéric Baron,Barry E. Storer,Michael B. Maris,Jan Storek,Fanny Piette,Monja D. Metcalf,Kristen White,Brenda M. Sandmaier,David G. Maloney,Rainer Storb,Michael Boeckh	2006	45
15	Juvenile Xanthogranuloma: A Congenital Giant Form Leading to a Wide Atrophic Sequela Pediatric Dermatology ·ASTRID IMIELA,O. Carpentier,M. Segard‐Drouard,Elisabeth Martin de Lassalle,Fanny Piette	2004	12
16	Blau syndrome of granulomatous arthritis, iritis, and skin rash: A new family and review of the literature American Journal of Medical Genetics ·Sylvie Manouvrier‐Hanu,Bernard Puech,Fanny Piette,O. Boute-Benejean,A. Desbonnet,B Duquesnoy,J P Farriaux	1998	61
17	A New Case of Isolated Trichothiodystrophy Dermatology ·S. Alfandari,Éric Delaporte,D. Van Neste,E. Lucidarme-Delespierre,Fanny Piette,H Bergoend	1993	13
18	[Pemphigus vulgaris induced by radiotherapy]. PubMed ·E. Delaporte,Fanny Piette,H Bergoend	1991	14
19	[Laser in dermatology: biological effects; indications (author's transl)]. PubMed ·G Rotteleur,Fanny Piette,Brunetaud Jm,P. THOMAS,H Bergoend	1981	1
20	[Multiple reticulo-histiocytoma]. PubMed ·Fanny Piette,Priscilla Thomas,Hilderbrand Hf,H Bergoend	1980	11

About Fanny Piette

Fanny Piette is a scholar working on Cancer Research, Oncology and Dermatology, having authored 24 papers that have together received 3.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Genomics and Diagnostics (3 papers), Histiocytic Disorders and Treatments (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (2.0k citations) and Immunology (695 citations). Fanny Piette has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Christos Sotiriou, Martine Piccart, Sherene Loi, Giuseppe Viale, Marc Buyse, Fátima Cardoso, Angelo Di Leo, Adrian L. Harris, Rosette Lidereau and Peter Ellis. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact